Blog
RSS FeedPosted by Michael Wonder on 08 May 2019
In Canada, a little known drug regulator shows its teeth
8 May 2019 - A tiny, little-known government agency is ramping up regulation of Canada’s pharmaceutical industry, seeking to rein in ...
Posted by Michael Wonder on 10 Apr 2019
Canada needs to read the fine print on pharma costs
10 April 2019 - The proposed federal price controls for patented medicines will send the wrong signal to Canadian and global ...
Posted by Michael Wonder on 29 Mar 2019
Canada’s amendment to patented drug price regulation: a prescription for global drug cost control?
29 March 2019 - The cost of drugs in the United States has emerged as a focal point for reducing overall ...
Posted by Michael Wonder on 28 Feb 2019
Drug prices aren’t a big problem, but Ottawa’s trying to control the market anyway
28 February 2019 - New policies will reduce access to new medicines for patients and impose massive new costs on taxpayers. ...
Posted by Michael Wonder on 26 Feb 2019
Are low-priced drugs becoming an endangered species?
26 February 2019 - The price of Canada’s top-selling patented drugs has increased by 800 per cent over 10 years. ...
Posted by Michael Wonder on 20 Feb 2019
New drug landscape dominated by high cost medicines
19 February 2019 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, ...
Posted by Michael Wonder on 09 Feb 2019
U.S. PhRMA's fight to prevent lower Canadian drug prices
9 February 2019 - Drug industry turns up heat against Canada's drug price reforms. ...
Posted by Michael Wonder on 07 Feb 2019
Facing crackdown in Canada, drug makers offered billions in price cuts
6 February 2019 - Delayed rules would change countries Canada compares its prices to, dropping U.S. ...
Posted by Michael Wonder on 05 Feb 2019
Relief, but at what cost? The steep price of modern psoriasis medications
5 February 2019 - Biologics offer great relief to most, but hard to get coverage for. ...
Posted by Michael Wonder on 24 Jan 2019
Ottawa’s push for lower drug costs may hurt patients, stunt innovation
24 January 2019 - The federal government’s plan to lower prescription drug prices could impede access and thus limit the ...
Posted by Michael Wonder on 23 Jan 2019
Trudeau spreads the big Pharmacare myth that scores of Canadians can’t afford medicine
23 January 2019 - Across every income group, people pay more for media entertainment than prescription medicine. ...
Posted by Michael Wonder on 23 Jan 2019
The strange world of Canadian drug pricing
22 January 2019 - Imagine yourself in some hip new coffee shop. All you want is your standard cup to ...
Posted by Michael Wonder on 18 Jan 2019
Canada’s drug pricing regulator brings rare allegation of excessive pricing against Horizon Pharma
17 January 2019 - Canada’s drug-pricing regulator is accusing an Irish pharmaceutical company of charging an excessive price for a ...
Posted by Michael Wonder on 15 Nov 2018
Lowering the price of new drugs comes with too high a cost — Canadians' health
14 November 2018 - Ottawa wants to apply new price regulations, which will only cut manufacturer profits and deter the introduction ...
Posted by Michael Wonder on 22 Oct 2018
Hatred of big pharma won’t get us better drug prices
22 October 2018 - The story of how Remicade became Canada’s most lucrative drug with sales topping $1.1-billion – told ...